- ￥323 - 4800
- MedChemExpress(MCE)
- 美国
- HY-121488
- 2025年07月16日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
339303-87-6
- 规格：
10 mM * 1 mL/1 mg/5 mg/10 mg/50 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥960.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥323.0 |
| 规格： | 5 mg | 产品价格： | ￥850.0 |
| 规格： | 10 mg | 产品价格： | ￥1350.0 |
| 规格： | 50 mg | 产品价格： | ￥4800.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
GP130 receptor agonist-1
CAS No. : 339303-87-6
MCE 国际站：GP130 receptor agonist-1
产品活性：GP130 receptor agonist-1 是一种有效的、可透过血脑屏障并具有口服活性的 GP130 受体激动剂。GP130 receptor agonist-1 对 NMDA 诱导的神经毒性具有神经保护作用。
作用靶点：Interleukin Related
In Vitro: In SH-SY5Y cells, GP130 receptor agonist-1 (Compound 2) treatment showed a 2-fold increase in phosphorylation of STAT3 within 10 min at its regulatory Tyr705 site. In primary hippocampal neuronal cultures, the pSTAT3 levels are below levels of detection for GP130 receptor agonist-1 at all time points.
GP130 receptor agonist-1 treatment shows increases phosphorylation of AKT at its regulatory Thr308 site and phosphorylation of ERK1/2 at its regulatory Thr202/Tyr204 site in the serum free media condition in SH-SY5Y cells, and in primary cortical neurons.
In Vivo: For GP130 receptor agonist-1 (Compound 2), mice are dosed orally at 10 or 30 mg/kg, or injected subcutaneously (SQ) at 10 mg/kg, and euthanized after 1, 2, 4, 6, and 8 h post dose. At 2 h after SQ delivery at 10 mg/kg the brain Cmax is 161 ng/g while dosing at 30 mg/kg orally, results in the brain Cmax of 156 ng/g (0.57 μM). The brain to plasma ratio for 2 is ∼4:1 for oral 30 mg/kg and ∼7.5:1 for 10 mg/kg SQ injection.
相关产品：Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Orally Active Compound Library | Neuroprotective Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Heterocyclic Compound Library | Resatorvid | Disulfiram | Polyinosinic-polycytidylic acid | Deucravacitinib | Raleukin | Apilimod | Tocilizumab | Oxidopamine hydrobromide | Dupilumab | Theophylline | LMT-28 | Secukinumab | Clofazimine | Benzbromarone | Sodium metatungstate | Hydrocortisone hemisuccinate | SC144 | Diacerein | Muscone | JTE-607 | Ixekizumab | IL-17A inhibitor 1 | APY0201 | Vidofludimus | Prednisone acetate | Semapimod tetrahydrochloride | ODN 2216 | Triamcinolone
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Elucidating Agonist-Selective Mechanisms of G Protein-Coupled Receptor Desensitization
to agonist-dependent regulation. In the case of the μ-opioid receptor (MOPr), we have shown that two agonists, morphine and the peptide agonist DAMGO, can induce MOPr desensitization by different mechanisms involving largely protein kinase C
PPAR/ Agonist Increases the Expression of PGE2 Receptor Subtype EP4 in Human Lung Carcinoma Cells
an important role in the effort to help extend its dismal 5-year survival rate (2 (PGE2 ), and the prostag-landin E2 receptor subtype, EP4, promote the growth and progression of human nonsmall cell lung carcinoma (NSCLC), the most common lung carcinoma
The HIV-1 entry receptors are CD4 and a chemokine receptor (CCR5 or CXCR4). In addition it has recently been demonstrated that HIV-1 gp120 binds to and signals through integrin α4 β7 , the gut-homing receptor (Arthos et al., Nat Immunol
技术资料暂无技术资料 索取技术资料
